Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

A specific thyroid hormone resistance mutation may be linked to different types of hair loss.

Certain genetic variants increase the risk of resistance to hormone therapy in prostate cancer patients.

A girl with rickets and hair loss was found to have a rare condition where her body didn't respond to vitamin D treatment.

A boy with severe Vitamin D-resistant rickets did not respond to treatment and lacked a common symptom, suggesting a need for alternative treatments.

A woman with a rare hormone resistance condition also had missing teeth and hair loss, which might be new symptoms of her genetic disorder.

Skin problems can be signs of hormone-related disorders and recognizing them early is important for treatment.

Mutations in the vitamin D receptor cause hereditary vitamin D-resistant rickets, leading to poor bone health and requiring high calcium doses for treatment.

Two siblings with a rare type of rickets and hair loss had low vitamin D levels, which is not typical for their condition.

Two rare genetic diseases cause severe rickets in children due to defects in vitamin D metabolism.

The conclusion is that genetic changes in the glucocorticoid receptor can lead to conditions affecting stress response, immunity, and metabolism, requiring personalized treatment.

A new mutation in the human glucocorticoid receptor reduces its function and causes resistance to glucocorticoids.

The conclusion is that there's a link between high testosterone levels, insulin resistance, and certain skin conditions, regardless of obesity.

Vitamin D is important for bones, hair, blood pressure, and breast development.

The review suggests thorough evaluation and genetic testing for proper diagnosis and treatment of Chrousos syndrome.

Mutations in certain receptors can cause diseases and offer new treatment options.

The document explains how the male reproductive system works, its role in making testosterone, and how conditions like obesity can disrupt it, leading to low testosterone and fertility issues.

Thyroid diseases may contribute to autoimmune skin diseases, and more research is needed on their relationship.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Only minoxidil and finasteride are FDA-approved for hair loss, with other treatments available but less effective or with side effects.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

Hormones are crucial for regulating body functions and imbalances can lead to health issues.

A woman with anorexia and Cushing's syndrome improved after tumor removal, highlighting the need to consider hormonal issues in psychiatric conditions.

Some women with PCOS have rare genetic variants linked to the condition.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

IGF-1 may affect hair growth and loss, but more research is needed to confirm effective and safe treatments.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Raspberry ketone may help grow hair and improve skin elasticity.

Experts agree on how to manage sugar levels and skin reactions in patients taking the cancer drug alpelisib.

Intravenous calcium therapy is a safe and effective treatment for a rare type of rickets.